Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis.
The synthesis, structure-activity relationships (SAR) and biological evaluation of thiazole based tricyclic inhibitors of IKK2 are described. Compound 9 was determined to be orally efficacious in a murine model of rheumatoid arthritis.
Dyckman, AJ; Langevine, CM; Quesnelle, C; Kempson, J; Guo, J; Gill, P; Spergel, SH; Watterson, SH; Li, T; Nirschl, DS; Gillooly, KM; Pattoli, MA; McIntyre, KW; Chen, L; McKinnon, M; Dodd, JH; Barrish, JC; Burke, JR; Pitts, WJ
Volume / Issue
Start / End Page
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)